MedTrace Logo

Tympanoseal (Tympanic Membrane Device) Clinical Study

NCT02918942 · Status: COMPLETED · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2024-10-15

Study results available
· View outcomes & findings →

Summary

The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or traumatic injury of the tympanic membrane.

Conditions

  • Tympanic Membrane Perforation

Interventions

DEVICE

Tympanoseal

All subjects will receive the Tympanoseal device that will be placed during a surgical procedure.

Sponsors & Collaborators

  • Grace Medical, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-04
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02918942 on ClinicalTrials.gov